• 제목/요약/키워드: Cardiovascular disease monitoring

검색결과 73건 처리시간 0.025초

Lovastatin과 Simvastatin의 고지혈증 치료 비교 (A Comparison of Lovastatin and Simvastatin in Treatment of Hyperlipidemia)

  • 조정주;이숙향
    • 한국임상약학회지
    • /
    • 제12권1호
    • /
    • pp.39-50
    • /
    • 2002
  • Hypercholesterolemia is one of main causes of coronary heart disease(CHD). Clinical trials demonstrated that lowering serum cholesterol levels would reduce incidence of new cardiovascular events and mortality by primary or secondary preventions. The objective of this retrospective study was to compare efficacy and side effects of lovartatin and simvastatin in treatement of hypercholesterolemia. In Boramae Hospital, patients were included when they have taken lovastatin 20 mg or simvastatin 10 mg for 52 weeks with laboratory monitoring for cholesterol at baseline, 3, 6 and 12 month period. As results, total 128 outpatients were included with their total cholesterol level <240 mg/dl and triglyceride level <400 mg/dl at baseline. Total cholesterol and LDL cholesterol of lovastatin group (n=60) and simvastatin group (n=68) were significantly reduced from baseline (p=0.001). Lovastatin maximally reduced total cholesterol by $23.9\%,\;triglyceride\;by\;12.3\%$, LDL cholesterol by $36.1\;\%$ and increased HDL cholerterol by $7.8\%$ and simvastatin reduced by $24.1\%,\;20.5\%,\;34.3\%\;respectively$ and HDL increased by $11.2\%$. There were no significant differences between lovastatin and simvastatin in mean percent change of lipid levels at 12, 24 and 52 weeks from baseline. Cumulative percentage of patients reaching the target LDL cholesterol concentration by 24 weeks was $61.7\%$ in lovastatin and $64.7\%$ in simvastatin. Average time to reach the target LDL goal was 100.1 days in lovastatin and 99.8 days in simvastatin. Both lovastatin and simvastatin also significantly reduced total cholesterol and LDL cholesterol in all subgroups (diabetes mellitus, hypertension, and coronary heart disease). In this study, treatment efficacy in patients with coronary heart disease was lower than other patients. Considering clinical importance of secondary prevention, more intensive treatment is necessary to decrease LDL cholesterol level of 100 mg/dl or lower in patients with coronary heart disease or other clinical atherosclerotic disease. There were no serious side effects during the study period. Digestive side effects were most frequently reported (lovastatin $8.3\%\;vs\;simvastatin\;8.8\%$). In conclusion, both lovastatin and simvastatin were similar in lipid lowering effects and there was no difference in incidence of side effects.

  • PDF

식이이행 의도증진을 위한 중재가 고지혈증 근로자의 식이이행 의도 및 식이이행도에 미치는 영향 (The Effects of the Intention Promotion Program on the Diet of Workers with Hyperlipemia based on the Theory of planned Behavior)

  • 현혜진;박연환
    • 한국직업건강간호학회지
    • /
    • 제9권1호
    • /
    • pp.39-48
    • /
    • 2000
  • Hyperlipemia is the most leading risk factor of cardiovascular disease which is the main cause of death in Korea. However, there is a tendency to neglect the prevention and treatment since it has no specific symptoms. It has been reported that the level of serum-lipid can be lowered by the improvement of eating habits. Therefore, it is highly likely that the development of programs on the improvement of eating habits through behavioral theory is required to the community nursing practice. The theory of planned behavior, which assumes that human behaviors are determined by one's intention to carry out the behavior, can be characterized by the point that behaviors are not only individual factors but also social behaviors relating to subjective norms. It is widely recognized that this theory has a high predictability on health behavior due to it's simplicity clearness, and measurability as well as high quality of being general. Thus, the theory of planned behavior could be useful in developing a model of a health promotion program to the change of behaviors of the risk group of cardiovascular disease. Consequently, based on the theory of planned behavior, the purpose of this study is to develop an intention promotion program of the diet, and then to testify the effects. The sample of this study consisted of 26 industrial workers who had proved hyperlipemia from a medical examination in 1996 (experimental group 13, control group 13). The intention promotion program, which includes education, monitoring, pressure, counselling on the level of individuals, families and organizations, was conducted for 10 weeks The purpose of this program was to promoting intention of the diet through changes of the prerequisite factors of intention such as behavioral belief, outcome evaluation, normative belief and control belief. When it came to data analysis, the ${\chi}^2$-test and Fisher's Exact test were used to compare the general characteristics between the experimental and the control group, an independent t-test for the other variables. ANOVA was used to the test hypothesis, and the Pearson correlation test for variable's correlation. The results of this study can be summarized as follows ; 1) There was a significant increase in the intention(F=18.51, p=.00) of diet in the experimental group. 2) Diets(F=32.51, p=.001) in the experimental group were better carried out than in the control group. 5) There was a moderate correlation between the intention of diet and performance (r=.587. p=.003). From the results, it can be concluded that the intention promotion program is very effective, leading to the change of health promotion behavior. Above all, it is really valuable that the intention promotion program in this study regards health promotion behavior as a social behavior and that intervention was done on the level of family and organization. Consequently, when performing a health promotion program, social approach elevating the intention should go hand in hand in order to make the program effective.

  • PDF

지역간 상대위험도 변동을 고려한 미세먼지 기인 질병부담 및 사회경제적 비용 추정 연구 (Health and Economic Burden Attributable to Particulate Matter in South Korea: Considering Spatial Variation in Relative Risk)

  • 변가람;최용수;길준수;차준일;이미혜;이종태
    • 한국환경보건학회지
    • /
    • 제47권5호
    • /
    • pp.486-495
    • /
    • 2021
  • Background: Particulate matter (PM) is one of the leading causes of premature death worldwide. Previous studies in South Korea have applied a relative risk calculated from Western populations when estimating the disease burden attributable to PM. However, the relative risk of PM on health outcomes may not be the same across different countries or regions. Objectives: This study aimed to estimate the premature deaths and socioeconomic costs attributable to long-term exposure to PM in South Korea. We considered not only the difference in PM concentration between regions, but also the difference in relative risk. Methods: National monitoring data of PM concentrations was obtained, and missing values were imputed using the AERMOD model and linear regression model. As a surrogate for relative risk, hazard ratios (HRs) of PM for cardiovascular and respiratory mortality were estimated using the National Health Insurance Service-National Sample Cohort. The nation was divided into five areas (metropolitan, central, southern, south-eastern, and Gangwon-do Province regions). The number of PM attributable deaths in 2018 was calculated at the district level. The socioeconomic cost was derived by multiplying the number of deaths and the statistical value of life. Results: The average PM10 concentration for 2014~2018 was 45.2 ㎍/m3. The association between long-term exposure to PM10 and mortality was heterogeneous between areas. When applying area-specific HRs, 23,811 premature deaths from cardiovascular and respiratory disease in 2018 were attributable to PM10 (reference level 20 ㎍/m3). The corresponding socioeconomic cost was about 31 trillion won. These estimated values were higher than that when applying nationwide HRs. Conclusions: This study is the first research to estimate the premature mortality caused by long-term exposure to PM using relative risks derived from the national population. This study will help precisely identify the national and regional health burden attributed to PM and establish the priorities of air quality policy.

클로자핀을 투여한 조현병 환자에서 혈소판 활성 증가에 관한 후향적 연구 (Clozapine Administration Potentiate Platelet Activation in Patients with Schizophrenia : Retrospective Study)

  • 김현아;이종욱;김승준;오홍석;임우영;김지웅
    • 정신신체의학
    • /
    • 제26권2호
    • /
    • pp.188-193
    • /
    • 2018
  • 연구목적 클로자핀은 조현병 치료에 널리 처방되는 항정신병약물로, 대사성 부작용 등으로 인한 심뇌혈관질환의 위험을 증가시키는 것으로 알려져 있다. 하지만, 클로자핀이 심뇌혈관질환의 발생에 중요한 영향을 미치는 또 다른 요소인 혈소판 활성 정도에 어떤 영향을 미치는지에 대해서는 알려진 바가 거의 없다. 본 연구에서는 클로자핀 투여 전후 평균혈소판요소 (mean platelet component, MPC) 값 비교를 통하여 조현병 환자에서 클로자핀이 혈소판 활성에 미치는 영향을 알아보고자 하였다. 방 법 2003년 9월 1일부터 2007년 4월 30일까지의 기간 동안 건양대학교 병원 정신건강의학과에서 클로자핀을 새롭게 투여 받기 시작한 환자들을 대상으로 의무기록을 후향적으로 검토 하였다. 최종 통계 분석에는 14명이 포함되었다. 평균혈소판요소는 Bayer ADVIA $120^{(R)}$ system를 이용하여 측정하였다. 결 과 14명의 연구 대상자 중, 남성은 4명(28.60%), 여성은 10명(71.40%)이었으며, 평균 나이는 $37.50{\pm}11.64$세였다. 유병 기간은 평균 $91.00{\pm}93.96$개월 이었으며 피험자들이 마지막 혈액 검사를 한 시점에 복용하였던 클로자핀 용량의 평균은 $337.50{\pm}109.52mg$이었다. 클로자핀 투여 전과 투여 후의 평균혈소판요소 값은 각각 $26.12{\pm}2.22g/dL$$25.14{\pm}2.08g/dL$ 이었다. 윌콕슨 부호-순위 검정에서 클로자핀 투여 후 MPC 값이 유의미하게 감소하였다(V=16, p=0.024). 결 론 본 연구의 결과는 클로자핀 투여가 혈소판을 활성화하며, 이로 인해 혈전색전성 질환 등의 발생에 부정적인 영향을 미칠 수 있음을 시사한다. 또한 클로자핀 투여 시 혈소판 활성에 대한 평가를 포함하여 뇌혈관질환의 위험성에 대한 주의 깊은 모니터링이 필요함을 시사한다.

당뇨병 유병기간에 따른 당뇨병 환자의 심혈관 위험 인자: 국민건강영양조사 6기 자료 이용 (Cardiovascular Risk Factors in Diabetic Patients according Duration of Diabetes Mellitus: The Sixth Korea National Health and Nutrition Examination Survey)

  • 김희성
    • 한국콘텐츠학회논문지
    • /
    • 제18권12호
    • /
    • pp.208-217
    • /
    • 2018
  • 당뇨병 유병기간에 따른 심혈관 질환의 혈청학적, 합병증의 양상을 국민건강영양조사 6기(2013-2015)의 모든 가용 데이터를 사용하여 당뇨병 환자의 치료뿐 아니라 향후 관리에 대한 정보를 제공함에 목적을 두고 있다. 국민건강영양조사는 건강 설문, 검진, 영양조사로 이루어져 있으며, 18~80세 미만으로 나이를 제한하였고, 당뇨병 유병기간을 응답한 1,316명을 조사 대상으로 하였다. 당뇨병 유병기간에 따라 0-5, 6-10, 11-15, 16-20, 20년 이상으로 구분하였다. 당뇨병 유병기간이 길어질수록 나이는 많아지고, BMI는 낮고, 흡연자의 비율은 떨어지며, HbA1c는 상승하고 사구체 여과율은 낮아졌다. 총 콜레스테롤, LDL-C, 중성 지방 수치는 낮고, HDL-C 수치는 비슷하였다. 인슐린 및 경구용 항고혈당제제를 치료 받는 환자의 비율은 증가하였다. 당뇨병 기간이 길수록 혈당 조절이 악화되었고, 미세혈관 및 대혈관합병증의 위험도는 상승하였다. 이러한 합병증을 예방하기 위해 집중적인 치료와 모니터링으로 위험요인을 통제해야 할 것이다.

Histological Validation of Cardiovascular Magnetic Resonance T1 Mapping for Assessing the Evolution of Myocardial Injury in Myocardial Infarction: An Experimental Study

  • Lu Zhang;Zhi-gang Yang;Huayan Xu;Meng-xi Yang;Rong Xu;Lin Chen;Ran Sun;Tianyu Miao;Jichun Zhao;Xiaoyue Zhou;Chuan Fu;Yingkun Guo
    • Korean Journal of Radiology
    • /
    • 제21권12호
    • /
    • pp.1294-1304
    • /
    • 2020
  • Objective: To determine whether T1 mapping could monitor the dynamic changes of injury in myocardial infarction (MI) and be histologically validated. Materials and Methods: In 22 pigs, MI was induced by ligating the left anterior descending artery and they underwent serial cardiovascular magnetic resonance examinations with modified Look-Locker inversion T1 mapping and extracellular volume (ECV) computation in acute (within 24 hours, n = 22), subacute (7 days, n = 13), and chronic (3 months, n = 7) phases of MI. Masson's trichrome staining was performed for histological ECV calculation. Myocardial native T1 and ECV were obtained by region of interest measurement in infarcted, peri-infarct, and remote myocardium. Results: Native T1 and ECV in peri-infarct myocardium differed from remote myocardium in acute (1181 ± 62 ms vs. 1113 ± 64 ms, p = 0.002; 24 ± 4% vs. 19 ± 4%, p = 0.031) and subacute phases (1264 ± 41 ms vs. 1171 ± 56 ms, p < 0.001; 27 ± 4% vs. 22 ± 2%, p = 0.009) but not in chronic phase (1157 ± 57 ms vs. 1120 ± 54 ms, p = 0.934; 23 ± 2% vs. 20 ± 1%, p = 0.109). From acute to chronic MI, infarcted native T1 peaked in subacute phase (1275 ± 63 ms vs. 1637 ± 123 ms vs. 1471 ± 98 ms, p < 0.001), while ECV progressively increased with time (35 ± 7% vs. 46 ± 6% vs. 52 ± 4%, p < 0.001). Native T1 correlated well with histological findings (R2 = 0.65 to 0.89, all p < 0.001) so did ECV (R2 = 0.73 to 0.94, all p < 0.001). Conclusion: T1 mapping allows the quantitative assessment of injury in MI and the noninvasive monitoring of tissue injury evolution, which correlates well with histological findings.

개심수술후 심장부정맥에 대한 임상적 연구: 원인,빈도 및 치료 (Postoperative Arrhythmia after Open Heart Surgery - Cause, Incidence and It`s Management -)

  • 장병철
    • Journal of Chest Surgery
    • /
    • 제24권9호
    • /
    • pp.843-852
    • /
    • 1991
  • We prospectively studied postoperative cardiac arrhythmia after open heart surgery to analyze the types and incidence of cardiac arrhythmia and to predict preoperative risk factors. And also we evaluated the effectiveness of atrial and ventricular epicardial electrodes which were placed during operation Between March 1990 and August 1990, We had operated on in 211 patients and we studied 201 consecutive patients excluding 10 patients. The study group included 99 males and 102 female patients, ages 1 month to 75 years[Mean$\pm$SD=28.0$\pm$21.7 years]. Postoperatively, all patients were regularly seen by the cardiac surgeon and cardiologist, They had continuous electrocardiographic monitoring for the first 3 days, initially in the intensive care unit and were checked routine electrocardiography on the postoperative 7 days, The postoperative cardiac arrhythmia were analyzed and possible associations of this arrhythmia with various pre, intra, and postoperative factors were studied by univariate and multivariate discriminant analysis, The overall incidence of postoperative cardiac arrhythmia except relative sinus bradycardia was 36.8%;[74/201], The incidence of postoperative cardiac arrhythmia in acyanotic congenital heart disease: 19.4%, cyanotic congenital heart disease: 20.8%, cardiac arrhythmia surgery: 33.3%, acquired valvular heart disease: 60.9% and coronary artery occlusive disease: 38.9%. Both univariate and multivariate studies indicated the pre operative symptom duration[p = 0013], the duration of medication[p=0.003], presence of preoperative arrhythmia[p<0.001] and pre-operative left atrial dimension in echocardiography to be the factor promoting postoperative cardiac arrhythmia. Multivariate discriminant analysis showed that the presence of preoperative cardiac arrhythmia, bypass time and the duration of preoperative symptom duration conveyed considerable risk factor on post-operative arrhythmia. The atrial wire electrodes were used diagnostically in 36 and were used therapeutically in 89 among 201 patients. Atrial pacing were used to treat relative sinus bradycardia, accelerated junctional tachycardia or premature atrial or ventricular contractions in 51 patients. Atrioventricular sequential pacing were used in 16 patients and ventricular pacing were used in 20 patients. Hemodynamics were evaluated in 2 patients of relative sinus bradycardia before and after atrial pacing. The atrial pacing increased the amount of cardiac output to 15% more. Because of their great utility in the diagnosis and treatment of arrhythmias, we conclude that routine placement of atrial and ventricular electrodes at the time of operation is indicated regardless of the nature of the open-heart procedure.

  • PDF

혈중 CA 125 수치가 지속적으로 상승되었던 기관지확장증 1예 (A Case of Bronchiectasis with Elevated Serum CA 125 Level)

  • 신봉철;구태형;김상옥;형건덕;엄수정;이수걸;손춘희;김기남;이기남;노미숙;최필조
    • Tuberculosis and Respiratory Diseases
    • /
    • 제66권6호
    • /
    • pp.467-470
    • /
    • 2009
  • CA 125의 상승은 난소의 악성종양에 나타날 수 있지만 비특이적이다. CA 125의 상승은 다양한 양성 질환 혹은 악성 종양에서 나타날 수 있다. 저자들은 최근 지속적으로 혈중 CA 125 수치가 증가되어 있지만 경질 초음파, 흉부 CT, PET-CT 등에서 악성 종양이 발견되지 않은 기관지확장증 1예를 경험하였다. 14개월의 추적 관찰 기간 중에도 난소암과 같은 악성 종양은 발견되지 않고 기관지확장증에 병발된 폐렴 이외에는 특이 소견이 없어, 혈중 CA 125의 상승은 기관지확장증에 의한 급성 폐 손상에 의한 것으로 추정된다. 혈중 CA 125 수치의 상승은 환자의 임상 양상과 연관하여 조심스럽게 판단하여야 될 것으로 생각된다.

고혈압 관리를 위한 헬스레벨 7 FHIR 기반 생체정보 교환 서비스 모델 구현 (Implementation of Service Model to Exchange of Biosignal Information based on HL7 Fast Health Interoperability Resources for the hypertensive management)

  • 조훈;원주옥;홍해숙;김화선
    • 인터넷정보학회논문지
    • /
    • 제15권3호
    • /
    • pp.21-30
    • /
    • 2014
  • 고혈압은 전 세계의 심혈관 및 뇌혈관 질환의 중요한 사망 원인으로서 지속적인 혈압관리가 필요하다. 본 연구에서는 급성장하고 있는 모바일 헬스케어 환경에서 지속적으로 혈압 관리를 받을 수 있는 생체정보 교환 서비스 모델로서 HL7 FHIR을 선택하였다. 개발한 HL7 FHIR 프레임워크는 매니저(스마트폰)과 에이전트(혈압계) 간에 블루투스 헬스기기 프로파일과 통하여 IEEE 11073-10407 PHD 프로토콜로 통신하여 혈압정보를 획득한다. 테스트 결과 고혈압 환자의 혈압 모니터링, 측정기록관리, 문서 생성, 측정정보전송을 성공적으로 수행하였다. 실제 임상환경에서는 TCP/IP 프로토콜을 통해 측정정보를 전송할 수 있으므로 모바일 헬스케어에서 지속적인 연구와 활성화가 기대된다.

심전도기반 u-Healthcare 시스템을 위한 파형추출 방법 (Development of Signal Detection Methods for ECG (Electrocardiogram) based u-Healthcare Systems)

  • 민철홍;김태선
    • 전자공학회논문지CI
    • /
    • 제46권6호
    • /
    • pp.18-26
    • /
    • 2009
  • 본 논문에서는 심전도 기반의 u헬스케어시스템을 위한 다용도 신호추출 방법을 제안한다. 심전도 기반의 u헬스케어시스템 구현을 위해서는 심장질환 진단을 위한 QRS파형의 추출기술이 필수적이다. 또한, 보안성 및 편의성을 위하여 u헬스케어시스템에서 ECG신호와 같은 생체신호에서 직접 사용자의 신원을 확인할 수 있는 생체인식기능을 보유하고 있다면 매우 유용하다. 이를 위해서 본 논문에서는, 리드II 파형으로부터 QRS파형을 추출하고, 또한 상대적으로 노화 및 질환에 따른 변동에 강건한 리드III 파형으로부터 생체인식을 위한 신호추출법을 제안한다. 리드II 파형으로부터 QRS신호추출성능을 검증하기 위해 MIT-BIH 데이터베이스의 심전도신호가 사용되었고 99.36%의 정확도 및 99.68%의 민감도성능을 보였다. 또한 생체인식용 신호추출성능평가를 위해서는 다양한 측정환경을 고려하기 위해 음주, 흡연 및 운동 직후 리드III파형이 측정되었고 99.92%의 정확도 및 99.97%의 민감도 성능을 보였다.